康宁杰瑞制药-B（09966）今日盘中大涨6.22%，引发市场关注。截至发稿时，该股报7.8港元，成交额达1841.92万港元。
业绩方面，康宁杰瑞制药近日公布的年度业绩显示，公司全年收入达人民币6.4亿元，同比大幅增长192.58%。更值得注意的是，公司扭亏为盈，实现年度溢利人民币1.66亿元。公司表示，这一亮眼业绩主要得益于三项授权合作和销售收入的贡献。
此外，公司HER2双特异性抗体偶联药物（ADC）JSKN003近期获得国家药品监督管理局（NMPA）药品审评中心（CDE）授予的突破性疗法认定，适用于治疗铂耐药复发性上皮性卵巢癌、原发性腹膜癌或输卵管癌，且不限HER2表达水平。这一认定有望加快JSKN003的临床开发和审评审批进程，进一步增强了投资者对公司未来发展前景的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.